Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ICR_CTSU
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ICR_CTSU
-
Thank you to our colleagues who held a cake sale and wrote pledges to raise money for
@CRUK and to mark#WorldCancerDay
pic.twitter.com/AGUrKguPph
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ICR-CTSU proslijedio/la je Tweet
A great delight to spend
#WorldCancerDay
helping junior investigators @ECMC_UK#JING20 develop their cancer trials. Exciting ideas! Ended the day with an unplanned “speed trial-designing” session with several trainees. It is such a privilege to be a statistical methodologist.
pic.twitter.com/0OqzbIcDNg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to all participants and colleagues who contribute to our clinical trials.
#IAmAndIWill
pic.twitter.com/32YDYebBZAPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We work with colleagues across the UK and internationally to design, conduct and analyse
#clinicaltrials with the aim to change clinical practice. Find out more about the work we do here: http://bit.ly/2GXebla#WorldCancerDay
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This
#WorldCancerDay
our director Judith Bliss and Ops director @clairesnowdon24 are presenting@ukhomeoffice on our cancer research and how@CR_UK supports cancer research@ICR_London and nationwide.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interested in working with us as a trial administrator? We are currently recruiting: http://bit.ly/38V36xc
#clinicaltrials#jobsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Prof Bliss was in Madrid last night, delivering a keynote speech
@GEICAM on the design of non-inferiority trials.https://twitter.com/anderu71/status/1222468264611151873 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ICR-CTSU proslijedio/la je Tweet
This would be of particular interesting for rna-seq based
#pam50@nanostringtech@ProsignaIVDhttps://twitter.com/HollyTovey/status/1221822511568031744 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Holly, one of our PhD students is presenting her work today
#UKIBCS2020https://twitter.com/HollyTovey/status/1221822511568031744?s=19 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This week we're at
#UKIBCS2020. Our Director, Prof Judith Bliss, went to the patient advocate session yesterday - great to kick off the conference by discussing their key research priorities.@uk_ibcs#whywedoresearchhttps://twitter.com/ICPVtweets/status/1221479446273843200 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our thanks to all of the participants and colleagues across the UK who contributed to this research
#bladdercancerPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The radiotherapy results were published in the Red Journal
@ASTRO_orghttp://bit.ly/2tQBhqKPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The results of the chemotherapy part of the trial were published in the
@NEJMhttp://bit.ly/2RLYJNXPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We found that adding chemotherapy to radiotherapy for treatment of
#bladdercancer did not detrimentally impact participants’ quality of life –http://bit.ly/2REmWWjPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re pleased that the patient reported quality of life study conducted as part of our BC2001
#bladdercancer trial has now been published. http://bit.ly/2sUqrjf@robert_huddart@Prof_Nick_James and@BhamCTUPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ICR-CTSU proslijedio/la je Tweet
Visual abstract with results from our 111 study
@ICR_CTSU@EmmaHall71https://twitter.com/EUplatinum/status/1214132236368404481 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Last week,
@MaggieCheang was on@BBCWorld discussing the new study from@imperialcollege and@GoogleHealth using#AI to detect breast cancer from mammograms. She looks forward to the normalisation of images across platforms, and validation of the method in#clinicaltrials.pic.twitter.com/CdxrGSvMnlHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Find out more about the 111
#testicularcancer trial on our web page: http://bit.ly/39FioYd , or read the results of the trial here: http://bit.ly/36uy6Ds .https://twitter.com/EmmaHall71/status/1213036887142625280 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Merry Christmas and Happy New Year to all our trial participants, collaborators and followers! Thank you for your continued support this year.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Following the presentations at San Antonio, we have had a lot of press interest for
#plasmaMATCH. Thank you to all of those involved. Find out more about the trial here: http://bit.ly/392wpPnPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.